V

PriceVerrica Pharmaceuticals

VRCA

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Historical stock price chart and annual return over the past years

-93%

5 years

% Total

VRCA
-41%

5 years

Annual Return

VRCA